Scully M, Cataland SR, Peyvandi F, et al. Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura. ASH 59th Annual Meeting & Exhibition, abstract LBA-1.
ARI-0002h (cesni-cel) onderzocht bij patiënten met recidief/refractair multipel myeloom in HOVON 183-studie
okt 2025 | MM